Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients.

Abstract:

:A double-blind, randomized crossover study in 28 asthmatic patients assessed the relative therapeutic index for inhaled formoterol and salbutamol. Pre-drug administration FEV1 (mean 2.08 l) was 49-93% of predicted and reversibility 16-82% after inhalation of salbutamol. Patients inhaled single doses of formoterol (Oxis) (4.5,18 and 54 microg, delivered doses) via Turbuhaler, salbutamol (Ventolin) (200 and 1800 microg) via pressurized metered dose inhaler (pMDI) and placebo at intervals of 48 h or more. Individual maximum FEV1 and minimum S-K+ were calculated. Relative local (maximum FEV1) and systemic (minimum S-K+) dose potencies, and their ratio, the relative therapeutic index, were estimated using a non-linear mixed effect model. The drug effects were well tolerated and dose dependent. A log-linear approximation was used to describe the bronchodilatory effect, whereas a sigmoid approximation was more apt to describe the decrease in serum potassium concentration. A bivariate dose-response model based on these principles was fitted simultaneously to all data. The mean relative therapeutic index between formoterol 4.5-54 microg given via Turbuhaler and salbutamol 200-1800 microg given via pMDI was estimated to be 2.5 in favour of formoterol; this trend was not statistically significant.

journal_name

Respir Med

journal_title

Respiratory medicine

authors

Rosenborg J,Larsson R,Rott Z,Böcskei C,Poczi M,Juhász G

doi

10.1053/rmed.2002.1291

subject

Has Abstract

pub_date

2002-06-01 00:00:00

pages

412-7

issue

6

eissn

0954-6111

issn

1532-3064

pii

S0954-6111(02)91291-6

journal_volume

96

pub_type

临床试验,杂志文章,随机对照试验
  • Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

    abstract:BACKGROUND:Long-term corticosteroid use may increase cataract risk. The Lens Opacities Classification System (LOCS) III ranked lens opacities as Class 1: 0.5-0.9 unit; Class 2: 1.0-1.4 units; or Class 3: ≥1.5 units in clinical trials of combined mometasone furoate and formoterol (MF/F) administered by metered-dose inha...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.rmed.2014.04.015

    authors: Maspero J,Cherrez I,Doherty DE,Tashkin DP,Kuna P,Kuo WL,Gates D,Nolte H,Chylack LT Jr

    更新日期:2014-09-01 00:00:00

  • A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD.

    abstract:BACKGROUND:This study evaluated the dose-response and dosing interval of the novel long-acting muscarinic receptor antagonist (LAMA) GSK573719 in patients with COPD. METHODS:This randomized, double-blind, placebo-controlled, 3-way cross-over, incomplete block study evaluated 5 once-daily doses of GSK573719 (62.5-1000 ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2012.03.012

    authors: Donohue JF,Anzueto A,Brooks J,Mehta R,Kalberg C,Crater G

    更新日期:2012-07-01 00:00:00

  • Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.

    abstract:BACKGROUND:The efficacy and safety of 750-mg, 5-day levofloxacin was recently shown to be comparable to 500-mg, 10-day levofloxacin in a randomized, double-blind, multicentre clinical trial for mild-to-severe community-acquired pneumonia (CAP). This subgroup analysis attempted to compare the safety and efficacy of a sh...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2006.03.019

    authors: Shorr AF,Khashab MM,Xiang JX,Tennenberg AM,Kahn JB

    更新日期:2006-12-01 00:00:00

  • Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.

    abstract::Haemodynamic studies at rest and during exercise together with radionuclide ventriculography, pulmonary function and clinical well-being assessment were evaluated in ten patients with COPD and secondary pulmonary hypertension (mean PAP 25 mm Hg), before and after 6 months therapy with pirbuterol 20 mg thrice daily. De...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0954-6111(89)80061-7

    authors: Neilly JB,Carter R,Tweddel A,Martin W,Hutton I,Banham SW,Stevenson RD

    更新日期:1989-01-01 00:00:00

  • Microrint pulmonary function testing in older adults with an intellectual disability.

    abstract:BACKGROUND:Pulmonary function testing is not feasible in many adults with intellectual disabilities, because of difficulties with understanding and cooperation. AIMS:To investigate feasibility, repeatability and reproducibility of measuring airway resistance using the interrupter technique (MicroRint) in people aged 5...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.rmed.2009.05.021

    authors: Pouls KP,Alsema LE,van der Laan H,Evenhuis HM,Penning C

    更新日期:2009-12-01 00:00:00

  • What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.

    abstract:BACKGROUND:The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and respiratory specialists in the prescription of inhaler devices for asthma patients who initiated inhalation therapy. METHODS:We retrospectively analysed p...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2020.105937

    authors: Lavorini F,Bianco A,Blasi F,Braido F,Corsico AG,Di Marco F,Gentile A,Paggiaro PL,Pegoraro V,Pelaia G,Rogliani P,Santus P,Scichilone N,Soldi A,Canonica GW

    更新日期:2020-05-01 00:00:00

  • Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis.

    abstract:BACKGROUND AND OBJECTIVE:Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible interstitial lung disease with poor prognosis despite the recent availability of two antifibrotic drugs. Patients are more susceptible to cardiovascular comorbidities. In this study, we aimed to determine the impact of concom...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2020.106259

    authors: M Lambert E,A Wuyts W,Yserbyt J,De Sadeleer LJ

    更新日期:2020-11-26 00:00:00

  • Chronic respiratory symptoms, spirometry and knowledge of COPD among general population.

    abstract:RATIONALE:Infradiagnosis of chronic obstructive pulmonary disease (COPD) may be related to the lack of knowledge about the disease and/or the scarce use of diagnostic procedures. This study analyses the frequency of respiratory symptoms and the knowledge about COPD in the general population, together with the use of sp...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2006.02.024

    authors: Miravitlles M,de la Roza C,Morera J,Montemayor T,Gobartt E,Martín A,Alvarez-Sala JL

    更新日期:2006-11-01 00:00:00

  • Airway inflammation in patients affected by obstructive sleep apnea syndrome.

    abstract::Obstructive sleep apnea syndrome (OSAS) has been shown to be associated to upper airway inflammation. The object of the present study was to establish the presence of bronchial inflammation in OSAS subjects. In 16 subjects affected by OSAS, and in 14 healthy volunteers, airway inflammation was detected by the cellular...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2003.08.003

    authors: Salerno FG,Carpagnano E,Guido P,Bonsignore MR,Roberti A,Aliani M,Vignola AM,Spanevello A

    更新日期:2004-01-01 00:00:00

  • Expression of blood dendritic cell antigens (BDCAs) by CD1a+ human pulmonary cells.

    abstract:BACKGROUND:Myeloid and plasmacytoid dendritic cell (DC) subsets have been recently identified in the human lung based on their differential expression of Blood DC Antigens 1-3 (BDCAs). We investigated the expression of these antigens by isolated human pulmonary CD1a(+) DCs, namely Langerhan's cells. METHODS:Using an i...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2009.02.006

    authors: Tsoumakidou M,Kemp SJ,Thorley AJ,Zhu J,Dewar A,Jeffery PK,Tetley TD

    更新日期:2009-06-01 00:00:00

  • Perceived 10-year change in respiratory health: reliability and predictive ability.

    abstract:OBJECTIVE:To investigate the usefulness of a self-reported respiratory health transition question over 10 years through reliability, ability to capture long-term asthma trajectory and predictive ability. SETTINGS:In two 20-year cohorts (Asthma-E3N, n = 16,371, 61-88 years; EGEA, n = 1254, 27-82 years), perceived 10-ye...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2014.11.010

    authors: Sanchez M,Varraso R,Bousquet J,Clavel-Chapelon F,Pison C,Kauffmann F,Humbert M,Siroux V

    更新日期:2015-02-01 00:00:00

  • Smoking cessation in chronic obstructive pulmonary disease.

    abstract::Chronic obstructive pulmonary disease (COPD) is increasing in prevalence, and is predicted to become the third leading cause of deaths worldwide by 2020. The precise prevalence of COPD is not known, as many individuals with the disease are left undiagnosed, despite the requirement of only simple spirometry testing for...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2009.02.013

    authors: Tashkin DP,Murray RP

    更新日期:2009-07-01 00:00:00

  • An overview of nine clinical trials of salmeterol in an asthmatic population.

    abstract::In an attempt to establish the protection afforded by regular salmeterol use against induced bronchoconstriction in asthmatic patients, a meta-analysis was conducted on nine double-blind clinical trials that fulfilled the inclusion criteria. In each trial, subjects were randomly assigned to receive either salmeterol 5...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,meta分析

    doi:10.1016/s0954-6111(98)90012-9

    authors: Verberne AA,Fuller R

    更新日期:1998-05-01 00:00:00

  • Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis.

    abstract::It has been hypothesized that hepatocyte growth factor (HGF) may play an important role in regulating the growth of lung epithelium and in the regeneration of the lung as a paracrine or endocrine factor in idiopathic pulmonary fibrosis (IPF). Based on this background, serum HGF was measured in 31 IPF patients (21 male...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/s0954-6111(97)90083-4

    authors: Hojo S,Fujita J,Yoshinouchi T,Yamanouchi H,Kamei T,Yamadori I,Otsuki Y,Ueda N,Takahara J

    更新日期:1997-10-01 00:00:00

  • Effects by 8-bromo-cyclicAMP on basal and organic dust-induced release of interleukin-6 and interleukin-8 in A549 human airway epithelial cells.

    abstract::Inhalation of organic dust from a swine-confinement building leads to an intense inflammatory reaction with an increased number of inflammatory cells and mediators in the upper and lower respiratory tract of previously unexposed subjects. In vitro the dust induces cytokine release from epithelial cells and alveolar ma...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2002.1415

    authors: Burvall K,Palmberg L,Larsson K

    更新日期:2003-01-01 00:00:00

  • Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?

    abstract:BACKGROUND:Asthma treatment per Global Initiative for Asthma (GINA) guidelines targets airway remodeling and achievement of normal lung function. OBJECTIVE:To study inhaled steroid therapy on airway remodeling and achievement of normal lung function. SUBJECTS AND SET UP: Asthmatic patients were followed over 5 years ....

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2005.06.011

    authors: Bibi HS,Feigenbaum D,Hessen M,Shoseyov D

    更新日期:2006-03-01 00:00:00

  • Characteristics of pulmonary Mycobacterium avium-intracellulare complex (MAC) infection in comparison with those of tuberculosis.

    abstract::To clarify the clinical features of pulmonary Mycobacterium avium-intracellulare complex (MAC) infection, we retrospectively evaluated clinical manifestations, laboratory data, chest and maxillary sinus computed tomographic scans and induced sputum findings in 26 with MAC infection in comparison with 104 patients with...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2003.1496

    authors: Watanabe K,Fujimura M,Kasahara K,Yasui M,Myou S,Watanabe A,Nakao S

    更新日期:2003-06-01 00:00:00

  • Mental health among adults with asthma and chronic bronchitis. A population-based study in Spain.

    abstract:OBJECTIVES:To analyze the conditions of psychological dysfunction and positive mental health in patients with asthma and chronic bronchitis (CB), as compared to healthy individuals, and to identify the factors associated with these mental health indicators. METHODS:Cross-sectional study based on data obtained from the...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2012.03.021

    authors: de Miguel Diez J,García RJ,Hernandez Barrera V,Rodríguez PR,Maestu LP,Garrido PC

    更新日期:2012-07-01 00:00:00

  • Clinical application of inert gas Multiple Breath Washout in children and adolescents with asthma.

    abstract:INTRODUCTION:Children with asthma often have normal spirometry despite significant disease. The pathology of the small airways in asthma may be assessed using Multiple Breath Washout (MBW) and calculating the Lung Clearance Index (LCI). There are only few studies using MBW in children with asthma and existing data rega...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2014.07.003

    authors: Zwitserloot A,Fuchs SI,Müller C,Bisdorf K,Gappa M

    更新日期:2014-09-01 00:00:00

  • Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study.

    abstract::Bronchial asthma is a costly disease and the correlated social impact is ever increasing. The aim of the Social Impact of Respiratory Integrated Outcomes (SIRIO) study was to measure the health resources consumption and the costs generated in 1 year by asthmatic patients investigated in a real-life setting. This botto...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2007.07.011

    authors: Dal Negro RW,Micheletto C,Tosatto R,Dionisi M,Turco P,Donner CF

    更新日期:2007-12-01 00:00:00

  • Health status perception and airflow obstruction in five Latin American cities: the PLATINO study.

    abstract:BACKGROUND:COPD is a highly prevalent disease but underdiagnosed, undertreated and possibly under-recognized by patients. Limited information exists regarding patients' perception of COPD severity. We compared patients' general health status perception, degree of breathlessness and physical activity limitation with the...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.rmed.2009.03.005

    authors: Montes de Oca M,Tálamo C,Halbert RJ,Perez-Padilla R,Lopez MV,Muiño A,Jardim JR,Valdivia G,Pertuzé J,Moreno D,Menezes AM,PLATINO Team.

    更新日期:2009-09-01 00:00:00

  • Systemic inflammation and lung function: A longitudinal analysis.

    abstract:BACKGROUND:Systemic inflammation is associated with impaired lung function in healthy adults as well as in patients with lung disease. The mechanism for this association is unknown and it is unclear if systemic inflammation leads to impaired lung function or if poor lung function leads to inflammation. We explored the ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2015.12.007

    authors: Hancox RJ,Gray AR,Sears MR,Poulton R

    更新日期:2016-02-01 00:00:00

  • The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.

    abstract:BACKGROUND:The inhaled corticosteroid fluticasone furoate (FF) is efficacious as a once-daily treatment for the management of asthma. Asthma is associated with circadian changes, with worsening lung function at night. We compared the efficacy of once-daily FF in the morning or evening for the treatment of asthma. METH...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2015.12.011

    authors: Kempsford RD,Bal J,Baines A,Renaux J,Ravindranath R,Thomas PS

    更新日期:2016-03-01 00:00:00

  • Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.

    abstract:BACKGROUND:Fluticasone propionate and formoterol fumarate have been combined in a single inhaler (fluticasone/formoterol; flutiform(®)) for the maintenance treatment of asthma. This pooled analysis assessed the efficacy of fluticasone/formoterol versus fluticasone in patients who previously received inhaled corticoster...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2014.10.019

    authors: Papi A,Price D,Sastre J,Kaiser K,Lomax M,McIver T,Dissanayake S

    更新日期:2015-02-01 00:00:00

  • The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis.

    abstract:BACKGROUND:There is wide variation in the techniques deployed to diagnose tuberculosis in the UK, with little agreement on which tools or strategies are cost effective. This analysis therefore comprehensively evaluated the cost effectiveness of currently available diagnostic strategies for routine diagnosis of TB in th...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2011.10.005

    authors: Hughes R,Wonderling D,Li B,Higgins B

    更新日期:2012-02-01 00:00:00

  • Clinical audit of subjects with snoring & sleep apnoea/hypopnoea syndrome fitted with mandibular repositioning splint.

    abstract::Snoring and obstructive sleep apnoea/hypopnoea syndrome (OSAHS) are often treated with mandibular repositioning splints (MRS), but the efficacy and satisfaction of them has not been comprehensively addressed. A survey on the use of and satisfaction with MRS was posted to 177 patients referred by a hospital orthodontic...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2004.07.007

    authors: Izci B,McDonald JP,Coleman EL,Mackay TW,Douglas NJ,Engleman HM

    更新日期:2005-03-01 00:00:00

  • Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation.

    abstract:BACKGROUND:Bronchial stenosis (BS) is currently found in 7-15% of lung transplantation (LT) recipients. Current treatment strategies have included Nd:Yag laser, cryotherapy, bougie dilatation and stent placement. Bronchoscopic balloon dilatation has been used as alternative treatment in a few cases with controversial r...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2006.04.019

    authors: De Gracia J,Culebras M,Alvarez A,Catalán E,De la Rosa D,Maestre J,Canela M,Román A

    更新日期:2007-01-01 00:00:00

  • Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height.

    abstract::Measurement of exhaled nitric oxide is widely used in respiratory research and clinical practice, especially in patients with asthma. However, interpretation is often difficult, due to common interfering factors, and little is known about interactions between factors. We assessed the influences and interactions of fac...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2008.02.012

    authors: Dressel H,de la Motte D,Reichert J,Ochmann U,Petru R,Angerer P,Holz O,Nowak D,Jörres RA

    更新日期:2008-07-01 00:00:00

  • Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.

    abstract:BACKGROUND:The 6-minute walk test distance (6MWD) has been shown to be a valid and responsive outcome measure in patients with idiopathic pulmonary fibrosis (IPF). The analyses were based, however, on a single phase 3 trial and require validation in an independent cohort. OBJECTIVE:To confirm the performance character...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2015.04.008

    authors: Nathan SD,du Bois RM,Albera C,Bradford WZ,Costabel U,Kartashov A,Noble PW,Sahn SA,Valeyre D,Weycker D,King TE Jr

    更新日期:2015-07-01 00:00:00

  • Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

    abstract:BACKGROUND:Familial dysautonomia (Riley-Day syndrome, hereditary sensory autonomic neuropathy type-III) is a rare genetic disease caused by impaired development of sensory and afferent autonomic nerves. As a consequence, patients develop neurogenic dysphagia with frequent aspiration, chronic lung disease, and chemorefl...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2018.06.017

    authors: Kazachkov M,Palma JA,Norcliffe-Kaufmann L,Bar-Aluma BE,Spalink CL,Barnes EP,Amoroso NE,Balou SM,Bess S,Chopra A,Condos R,Efrati O,Fitzgerald K,Fridman D,Goldenberg RM,Goldhaber A,Kaufman DA,Kothare SV,Levine J,Levy

    更新日期:2018-08-01 00:00:00